Growth Metrics

Verastem (VSTM) Net Income towards Common Stockholders Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -10.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -46.86%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 34.98%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -31.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.97%
Dec 31, 2025 92.02%
Sep 30, 2025 -30.07%
Jun 30, 2025 -25.15%
Mar 31, 2025 -36.71%
Dec 31, 2024 -24.71%
Sep 30, 2024 -17.90%
Jun 30, 2024 -2.93%
Mar 31, 2024 -22.78%
Dec 31, 2023 -15.60%
Sep 30, 2023 -52.36%
Jun 30, 2023 4.11%
Mar 31, 2023 20.43%
Dec 31, 2022 23.91%
Sep 30, 2022 15.62%
Jun 30, 2022 19.56%
Mar 31, 2022 23.60%
Dec 31, 2021 23.56%
Sep 30, 2021 -1.69%
Jun 30, 2021 2.73%
Mar 31, 2021 10.62%
Dec 31, 2020 -2.56%
Sep 30, 2020 36.94%
Jun 30, 2020 -19.64%
Mar 31, 2020 -42.95%
Dec 31, 2019 -48.46%
Sep 30, 2019 -56.11%
Jun 30, 2019 -70.13%
Mar 31, 2019 -66.24%
Dec 31, 2018 -45.98%
Sep 30, 2018 -11.95%
Jun 30, 2018 -6.10%
Mar 31, 2018 -11.51%
Dec 31, 2017 -9.34%
Sep 30, 2017 -20.15%
Jun 30, 2017 -1.05%
Mar 31, 2017 0.15%
Dec 31, 2016 -0.96%
Sep 30, 2016 9.23%
Jun 30, 2016 5.80%
Mar 31, 2016 2.82%
Dec 31, 2015 -14.41%
Sep 30, 2015 -14.21%
Jun 30, 2015 -31.10%
Mar 31, 2015 -30.20%
Dec 31, 2014 -32.33%
Sep 30, 2014 -48.67%
Jun 30, 2014 -73.60%
Mar 31, 2014 -124.79%